Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U2SI
|
|||
Drug Name |
PMID27109571-Compound-21
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H26N6
|
|||
Canonical SMILES |
C1CCC(CC1)C2=NC3=C(CCCCC3)C(=C2C4=NNN=N4)C5=CC=NC=C5
|
|||
InChI |
1S/C22H26N6/c1-3-7-16(8-4-1)21-20(22-25-27-28-26-22)19(15-11-13-23-14-12-15)17-9-5-2-6-10-18(17)24-21/h11-14,16H,1-10H2,(H,25,26,27,28)
|
|||
InChIKey |
FMTDJMYDWZGVPK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Fatty acid-binding protein 4 (FABP4) | Target's Patent Info | [1] | |
Fatty acid-binding protein 5 (FABP5) | Target's Patent Info | [1] | ||
KEGG Pathway | PPAR signaling pathway | |||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathway Interaction Database | AP-1 transcription factor network | |||
Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
Transcriptional regulation of white adipocyte differentiation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | |||
Transcriptional Regulation of White Adipocyte Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.